# ONO-4538 Phase I Study in Patients With Advanced Malignant Solid Tumors in Japan

> **NCT00836888** · PHASE1 · COMPLETED · sponsor: **Ono Pharmaceutical Co., Ltd.** · enrollment: 17 (actual)

## Conditions studied

- Malignant Solid Tumor

## Interventions

- **BIOLOGICAL:** ONO-4538

## Key facts

- **NCT ID:** NCT00836888
- **Lead sponsor:** Ono Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2010-09
- **Final completion:** —
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2020-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00836888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00836888, "ONO-4538 Phase I Study in Patients With Advanced Malignant Solid Tumors in Japan". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00836888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*